These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30866796)

  • 1. Transcriptional profiling of PPARα-/- and CREB3L3-/- livers reveals disparate regulation of hepatoproliferative and metabolic functions of PPARα.
    Ruppert PMM; Park JG; Xu X; Hur KY; Lee AH; Kersten S
    BMC Genomics; 2019 Mar; 20(1):199. PubMed ID: 30866796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα.
    Nakagawa Y; Satoh A; Tezuka H; Han SI; Takei K; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Iwasaki Y; Sone H; Matsuzaka T; Yamada N; Shimano H
    Sci Rep; 2016 Dec; 6():39182. PubMed ID: 27982131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.
    Kim H; Mendez R; Zheng Z; Chang L; Cai J; Zhang R; Zhang K
    Endocrinology; 2014 Mar; 155(3):769-82. PubMed ID: 24424044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.
    Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H
    Endocrinology; 2014 Dec; 155(12):4706-19. PubMed ID: 25233440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
    Girer NG; Murray IA; Omiecinski CJ; Perdew GH
    J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition.
    Nakagawa Y; Wang Y; Han SI; Okuda K; Oishi A; Yagishita Y; Kumagai K; Ohno H; Osaki Y; Mizunoe Y; Araki M; Murayama Y; Iwasaki H; Konishi M; Itoh N; Matsuzaka T; Sone H; Yamada N; Shimano H
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):949-971. PubMed ID: 33246135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism.
    Berger JH; Charron MJ; Silver DL
    PLoS One; 2012; 7(11):e50629. PubMed ID: 23209793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Hepatic PPARα Activity Links GLUT8 Deficiency to Augmented Peripheral Fasting Responses in Male Mice.
    Mayer AL; Zhang Y; Feng EH; Higgins CB; Adenekan O; Pietka TA; Beatty WL; DeBosch BJ
    Endocrinology; 2018 May; 159(5):2110-2126. PubMed ID: 29596655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.
    Shao M; Shan B; Liu Y; Deng Y; Yan C; Wu Y; Mao T; Qiu Y; Zhou Y; Jiang S; Jia W; Li J; Li J; Rui L; Yang L; Liu Y
    Nat Commun; 2014 Mar; 5():3528. PubMed ID: 24670948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREBH Regulates Systemic Glucose and Lipid Metabolism.
    Nakagawa Y; Shimano H
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH/PPARα transcriptional program.
    Kim H; Wei J; Song Z; Mottillo E; Samavati L; Zhang R; Li L; Chen X; Jena BP; Lin JD; Fang D; Zhang K
    Mol Metab; 2021 Jul; 49():101192. PubMed ID: 33592335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.
    Yang Z; Roth K; Agarwal M; Liu W; Petriello MC
    J Nutr Biochem; 2021 Sep; 95():108633. PubMed ID: 33789150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
    Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
    Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
    Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.